How to buy Co-Diagnostics stock (CODX)

Co-Diagnostics is a medical devices business based in the US. Co-Diagnostics shares (CODX) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.76 – a decrease of 6.18% over the previous week. Co-Diagnostics employs 155 staff and has a trailing 12-month revenue of around $7.3 million.

Our top picks for where to buy Co-Diagnostics stock

Buy Co-Diagnostics stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Co-Diagnostics stock price (NASDAQ: CODX)

Use our graph to track the performance of CODX stocks over time.

Co-Diagnostics shares at a glance

• Key figures

Information last updated 2024-12-12.

Latest market close	$0.76
52-week range	$0.80 - $2.23
50-day moving average more info button	$1.13
200-day moving average more info button	$1.21
Wall St. target price	$1.50
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-1.38

Is it a good time to buy Co-Diagnostics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Co-Diagnostics price performance over time

Historical closes compared with the close of $0.7901 from 2024-12-16

1 week (2024-12-11)	-2.47%
1 month (2024-11-18)	-26.84%
3 months (2024-09-18)	-38.27%
6 months (2024-06-18)	-48.36%

1 year (2023-12-18)	-28.82%
2 years (2022-12-16)	-68.77%
3 years (2021-12-17)	8.66
5 years (2019-12-18)	1.013

Co-Diagnostics financials

Revenue TTM	$7.3 million
Gross profit TTM	$28.7 million
Return on assets TTM	-27.61%
Return on equity TTM	-50.57%
Profit margin	0%
Book value	$2.00
Market Capitalization more info button	$25.9 million

TTM: trailing 12 months

Co-Diagnostics share dividends

We're not expecting Co-Diagnostics to pay a dividend over the next 12 months.

Co-Diagnostics share price volatility

Over the last 12 months, Co-Diagnostics's shares have ranged in value from as little as $0.8043 up to $2.2299. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Co-Diagnostics's is -0.846. This would suggest that Co-Diagnostics's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Co-Diagnostics has bucked the trend.

Co-Diagnostics overview

Co-Diagnostics, Inc. , a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah. .

Frequently asked questions

null
What percentage of Co-Diagnostics is owned by insiders or institutions?
Currently 6.696% of Co-Diagnostics shares are held by insiders and 13.956% by institutions. How many people work for Co-Diagnostics?
Latest data suggests 155 work at Co-Diagnostics. When does the fiscal year end for Co-Diagnostics?
Co-Diagnostics's fiscal year ends in December. Where is Co-Diagnostics based?
Co-Diagnostics's address is: 2401 South Foothill Drive, Salt Lake City, UT, United States, 84109 What is Co-Diagnostics's ISIN number?
Co-Diagnostics's international securities identification number is: US1897631057 What is Co-Diagnostics's CUSIP number?
Co-Diagnostics's Committee on Uniform Securities Identification Procedures number is: 189763105